1. Home
  2. ALTI vs LAB Comparison

ALTI vs LAB Comparison

Compare ALTI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$3.86

Market Cap

407.2M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$1.00

Market Cap

365.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTI
LAB
Founded
2020
1999
Country
United States
United States
Employees
490
N/A
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
407.2M
365.2M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
ALTI
LAB
Price
$3.86
$1.00
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.35
AVG Volume (30 Days)
147.7K
3.2M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
41.11
61.54
EPS
N/A
0.33
Revenue
$254,956,000.00
$101,937,000.00
Revenue This Year
$18.06
N/A
Revenue Next Year
$10.71
$2.63
P/E Ratio
N/A
$3.05
Revenue Growth
23.21
N/A
52 Week Low
$2.96
$0.87
52 Week High
$5.45
$1.72

Technical Indicators

Market Signals
Indicator
ALTI
LAB
Relative Strength Index (RSI) 56.06 58.86
Support Level $3.73 $0.90
Resistance Level $3.96 $1.02
Average True Range (ATR) 0.21 0.05
MACD 0.03 0.01
Stochastic Oscillator 82.85 75.05

Price Performance

Historical Comparison
ALTI
LAB

About ALTI AlTi Global Inc.

AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: